会议亮点：乳腺癌辅助治疗 - Suppr

Suppr

超能文献

Meeting highlights: adjuvant therapy for breast cancer.

作者信息

Glick J H

机构信息

University of Pennsylvania Cancer Center, Philadelphia 19104-4283.

出版信息

J Natl Cancer Inst. 1988 Jun 1;80(7):471-5. doi: 10.1093/jnci/80.7.471.

DOI:10.1093/jnci/80.7.471

PMID:3367387

Abstract

摘要

相似文献

Meeting highlights: adjuvant therapy for breast cancer.会议亮点：乳腺癌辅助治疗

J Natl Cancer Inst. 1988 Jun 1;80(7):471-5. doi: 10.1093/jnci/80.7.471.

Adjuvant chemotherapy of early breast cancer.

Med Lett Drugs Ther. 1990 May 18;32(818):49-50.

Systemic adjuvant therapy for node-negative breast cancer: proven or premature?

Ann Intern Med. 1989 Jul 1;111(1):1-4. doi: 10.7326/0003-4819-111-1-1.

The role of adjuvant endocrine therapy in primary breast cancer.辅助内分泌治疗在原发性乳腺癌中的作用。

Recent Results Cancer Res. 1989;115:136-43. doi: 10.1007/978-3-642-83337-3_20.

Adjuvant tamoxifen therapy and receptor levels.

Lancet. 1985 Mar 9;1(8428):573. doi: 10.1016/s0140-6736(85)91224-3.

[Tamoxifen-induced progesterone receptors in breast tumors].

Vopr Onkol. 1991;37(9-10):916-21.

Adjuvant systemic therapy for early breast cancer.早期乳腺癌的辅助性全身治疗。

Lancet. 1992 Jan 4;339(8784):27.

Tamoxifen therapy, oestrogen receptor status, and postmenopausal breast cancer.

Lancet. 1985 Apr 27;1(8435):976. doi: 10.1016/s0140-6736(85)91739-8.

Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group.在淋巴结阳性、雌激素受体阳性乳腺癌患者中，化疗与他莫昔芬及化疗加他莫昔芬的比较：一项意大利多中心研究结果。乳腺癌辅助化疗-激素治疗协作组

J Clin Oncol. 1990 Aug;8(8):1310-20. doi: 10.1200/JCO.1990.8.8.1310.

Is there a place for adjuvant endocrine therapy of breast cancer?

Recent Results Cancer Res. 1980;71:178-84. doi: 10.1007/978-3-642-81406-8_27.

引用本文的文献

Meeting highlights: the first korean breast cancer treatment consensus conference.会议亮点：首届韩国乳腺癌治疗共识会议

J Breast Cancer. 2014 Dec;17(4):308-13. doi: 10.4048/jbc.2014.17.4.308. Epub 2014 Dec 26.

Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer.联合使用 ER/PR/HER2 亚型和 2007 年圣加仑共识声明进行早期乳腺癌治疗。

BMC Cancer. 2010 May 21;10:228. doi: 10.1186/1471-2407-10-228.

Predicting recurrence in axillary-node negative breast cancer patients.预测腋窝淋巴结阴性乳腺癌患者的复发情况。

Breast Cancer Res Treat. 1993;25(2):127-39. doi: 10.1007/BF00662138.

Male breast cancer: Austrian experience.男性乳腺癌：奥地利的经验。

World J Surg. 1995 Sep-Oct;19(5):687-92; discussion 692-3. doi: 10.1007/BF00295904.

Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.他莫昔芬：对其药效学、药代动力学特性及治疗用途的重新评估

Drugs. 1989 Apr;37(4):451-90. doi: 10.2165/00003495-198937040-00004.

Ethics of clinical research.临床研究伦理

BMJ. 1989 Sep 16;299(6701):737-8. doi: 10.1136/bmj.299.6701.737-c.

Mastectomy following preoperative chemotherapy. Strict operative criteria control operative morbidity.术前化疗后的乳房切除术。严格的手术标准可控制手术并发症。

Ann Surg. 1991 Feb;213(2):126-9. doi: 10.1097/00000658-199102000-00006.

Nuclear pleomorphism, a strong prognostic factor in axillary node-negative small invasive breast cancer.核多形性是腋窝淋巴结阴性的小浸润性乳腺癌的一个重要预后因素。

Breast Cancer Res Treat. 1992 Jan;20(2):109-16. doi: 10.1007/BF01834640.

Predicting outcome for patients with node negative breast cancer: a comparative study of the value of flow cytometry and cell image analysis for determination of DNA ploidy.预测淋巴结阴性乳腺癌患者的预后：流式细胞术和细胞图像分析在确定DNA倍体价值方面的比较研究

Br J Cancer. 1992 Mar;65(3):461-5. doi: 10.1038/bjc.1992.93.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验